(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are IMAC Holdings, Histogen, and Aspen Group.

The three biggest losers today are Akerna Corp., Fastly, and Hall of Fame Resort & Entertainment Company.

Winners today

1. IMAC Holdings (IMACW) – 37.78%

NASDAQ ended the session with IMAC Holdings jumping 37.78% to $0.01 on Thursday while NASDAQ dropped 0.12% to $13,219.83.

Yearly Top and Bottom Value

IMAC Holdings’s stock is valued at $0.01 at 17:32 EST, way above its 52-week high of $0.01.

More news about IMAC Holdings.

2. Histogen (HSTO) – 31.6%

Histogen Inc., a clinical-stage therapeutics company, focuses on developing therapeutics based upon the products of fibroblast cells grown under simulated embryonic conditions. It offers HST-001, a hair stimulating complex that is in Phase 1b/2a clinical trial for the treatment of androgenic alopecia (hair loss); HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; and Emricasan, an orally active pan-caspase inhibitor that is in Phase 1 clinical trial for the treatment of COVID-19. The company's pre-clinical programs include HST-004, a cell conditioned media (CCM) solution to treat spinal disc repair; and HST-002, a human-derived collagen and extracellular matrix dermal filler for the treatment of facial folds and wrinkles. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California.

NASDAQ ended the session with Histogen jumping 31.6% to $0.66 on Thursday, after two sequential sessions in a row of gains. NASDAQ slid 0.12% to $13,219.83, following the last session’s upward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, Histogen has a trailing twelve months EPS of $-5.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -102.91%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Histogen’s EBITDA is 1.

Yearly Top and Bottom Value

Histogen’s stock is valued at $0.66 at 17:32 EST, way below its 52-week high of $1.64 and way above its 52-week low of $0.36.

More news about Histogen.

3. Aspen Group (ASPU) – 11.7%

Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.

NASDAQ ended the session with Aspen Group rising 11.7% to $0.17 on Thursday, after three sequential sessions in a row of losses. NASDAQ slid 0.12% to $13,219.83, following the last session’s upward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, Aspen Group has a trailing twelve months EPS of $-0.33.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

More news about Aspen Group.

4. Liquidia Technologies (LQDA) – 7.62%

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. The company distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

NASDAQ ended the session with Liquidia Technologies jumping 7.62% to $6.92 on Thursday, after two successive sessions in a row of gains. NASDAQ slid 0.12% to $13,219.83, following the last session’s upward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Liquidia Technologies has a trailing twelve months EPS of $-0.78.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -62.53%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 50% and a negative 144.4%, respectively.

Moving Average

Liquidia Technologies’s value is below its 50-day moving average of $6.98 and below its 200-day moving average of $7.20.

Revenue Growth

Year-on-year quarterly revenue growth grew by 22.2%, now sitting on 17.8M for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Liquidia Technologies’s EBITDA is -18.92.

More news about Liquidia Technologies.

5. HighPeak Energy (HPKEW) – 6.56%

NASDAQ ended the session with HighPeak Energy jumping 6.56% to $10.39 on Thursday while NASDAQ dropped 0.12% to $13,219.83.

Moving Average

HighPeak Energy’s worth is way higher than its 50-day moving average of $7.53 and way below its 200-day moving average of $11.97.

More news about HighPeak Energy.

6. KalVista Pharmaceuticals (KALV) – 5.36%

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed a Phase II clinical trial for the treatment of DME; KVD900, which is in Phase II clinical trial for treating HAE attacks; and KVD824, an oral plasma kallikrein inhibitor that completed a Phase I clinical trial for treating DME or HAE. The company is headquartered in Cambridge, Massachusetts.

NASDAQ ended the session with KalVista Pharmaceuticals rising 5.36% to $9.04 on Thursday, following the last session’s upward trend. NASDAQ fell 0.12% to $13,219.83, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, KalVista Pharmaceuticals has a trailing twelve months EPS of $-2.94.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -62.64%.

More news about KalVista Pharmaceuticals.

7. Repro Med Systems (KRMD) – 4.1%

Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.

NASDAQ ended the session with Repro Med Systems rising 4.1% to $2.79 on Thursday, after two sequential sessions in a row of gains. NASDAQ fell 0.12% to $13,219.83, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Repro Med Systems has a trailing twelve months EPS of $-0.19.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -26.71%.

Volume

Today’s last reported volume for Repro Med Systems is 2591 which is 96.68% below its average volume of 78228.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 66.7% and a negative 25%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 5.9%, now sitting on 29.43M for the twelve trailing months.

More news about Repro Med Systems.

8. Rock (RKT) – 4.07%

Rocket Companies, Inc., a fintech holding company, provides mortgage lending, title and settlement services, and other financial technology services in the United States and Canada. It operates through two segments, Direct to Consumer and Partner Network. The company's solutions include Rocket Mortgage, a mortgage lender; Amrock that provides title insurance, property valuation, and settlement services; Rocket Homes, a home search platform and real estate agent referral network, which offers technology-enabled services to support the home buying and selling experience; Rocket Auto, a virtual marketplace where consumers can shop and compare vehicles of many makes and models from a wide network of dealers; and Rocket Loans, an online-based personal loans business. It also offers Core Digital Media, a digital, social, and display advertiser in the mortgage, insurance, and education sectors; Rocket Solar, a tech-driven, residential solar energy provider; Rocket Money, a personal finance app that helps clients manage every aspect of their financial lives; Lendesk, a software services company that provides a point of sale system for mortgage professionals and a loan origination system for private lenders; Rocket Central, a professional services organization that provides technology, data, marketing, communication and other services; Rock Connections, a sales and support platform specializing in contact center services; Rocket Innovation Studio that recruits and mentors top technology talent; and Edison Financial, a digital mortgage broker. In addition, the company originates, closes, sells, and services agency-conforming loans. Rocket Companies, Inc. was founded in 1985 and is headquartered in Detroit, Michigan. Rocket Companies, Inc. operates as a subsidiary of Rock Holdings Inc.

NYSE ended the session with Rock jumping 4.07% to $7.93 on Thursday, following the last session’s upward trend. NYSE rose 0.01% to $15,072.99, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Rock has a trailing twelve months EPS of $1.8.

PE Ratio

Rock has a trailing twelve months price to earnings ratio of 4.4. Meaning, the purchaser of the share is investing $4.4 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.8%.

Yearly Top and Bottom Value

Rock’s stock is valued at $7.93 at 17:32 EST, way under its 52-week high of $11.94 and way above its 52-week low of $5.97.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 75% and 110%, respectively.

Volume

Today’s last reported volume for Rock is 827703 which is 60.32% below its average volume of 2086330.

Revenue Growth

Year-on-year quarterly revenue growth declined by 10.8%, now sitting on 3.83B for the twelve trailing months.

More news about Rock.

9. Kingsoft Cloud Holdings Limited (KC) – 3.99%

Kingsoft Cloud Holdings Limited provides cloud services to businesses and organizations in China. The company offers public cloud services to customers in various verticals, including game, video, AI, e-commerce, education, and mobile internet; enterprise cloud services to customers in financial service, public service, and healthcare business, and others. It also provides IoT–smart living solutions. The company was incorporated in 2012 and is headquartered in Beijing, the People's Republic of China.

NASDAQ ended the session with Kingsoft Cloud Holdings Limited jumping 3.99% to $4.69 on Thursday while NASDAQ dropped 0.12% to $13,219.83.

Earnings Per Share

As for profitability, Kingsoft Cloud Holdings Limited has a trailing twelve months EPS of $-1.36.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -25.58%.

More news about Kingsoft Cloud Holdings Limited.

10. Aurora Cannabis (ACB) – 3.74%

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Leduc, Canada.

NYSE ended the session with Aurora Cannabis jumping 3.74% to $0.57 on Thursday while NYSE rose 0.01% to $15,072.99.

Earnings Per Share

As for profitability, Aurora Cannabis has a trailing twelve months EPS of $-5.64.

Volatility

Aurora Cannabis’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.60%, a positive 1.30%, and a positive 5.08%.

Aurora Cannabis’s highest amplitude of average volatility was 3.60% (last week), 10.30% (last month), and 5.08% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Aurora Cannabis’s stock is considered to be overbought (>=80).

More news about Aurora Cannabis.

Losers Today

1. Akerna Corp. (KERNW) – -42.56%

NASDAQ ended the session with Akerna Corp. falling 42.56% to $0.01 on Thursday, after five sequential sessions in a row of losses. NASDAQ dropped 0.12% to $13,219.83, following the last session’s upward trend on what was a somewhat bearish trend exchanging session today.

Yearly Top and Bottom Value

Akerna Corp.’s stock is valued at $0.01 at 17:32 EST, way below its 52-week low of $0.01.

More news about Akerna Corp..

2. Fastly (FSLY) – -13.42%

Fastly, Inc. operates an edge cloud platform for processing, serving, and securing its customer's applications in the United States, the Asia Pacific, Europe, and internationally. The edge cloud is a category of Infrastructure as a Service that enables developers to build, secure, and deliver digital experiences at the edge of the internet. It is a programmable platform designed for web and application delivery. The company offers Compute@Edge; network services to speed up and optimize the delivery of web and application traffic; device detection and geolocation; content delivery network, such as dynamic site acceleration, origin shield, instant purge, surrogate keys, programmatic control, content compression, reliability, and modern protocols and performance services; and streaming solutions and services, including live streaming and media shield. It also provides edge security solutions, such as DDoS protection, next-gen WAF, bot protection, API and ATO protection, advanced rate limiting, and compliance services; transport layer security (TLS) and platform TLS; and origin connect. In addition, the company offers edge applications, such as load balancers and image optimizers; video on demand; and edge delivery services. It serves customers operating in digital publishing, media and entertainment, technology, online retail and education, SaaS, travel and hospitality, and financial services industries. The company was formerly known as SkyCache, Inc. and changed its name to Fastly, Inc. in May 2012. Fastly, Inc. was incorporated in 2011 and is headquartered in San Francisco, California.

NYSE ended the session with Fastly sliding 13.42% to $15.80 on Thursday while NYSE jumped 0.01% to $15,072.99.

Earnings Per Share

As for profitability, Fastly has a trailing twelve months EPS of $-1.24.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 50% and 50%, respectively.

Sales Growth

Fastly’s sales growth is 22.6% for the current quarter and 17.4% for the next.

Volatility

Fastly’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.87%, a negative 1.55%, and a positive 3.35%.

Fastly’s highest amplitude of average volatility was 3.43% (last week), 2.69% (last month), and 3.35% (last quarter).

More news about Fastly.

3. Hall of Fame Resort & Entertainment Company (HOFV) – -10.52%

Hall of Fame Resort & Entertainment Company, a resort and entertainment company, doing business as the Pro Football Hall of Fame. It owns the premier sports, entertainment, and media enterprise surrounding the Pro Football Hall of Fame in Canton, Ohio. The company was founded in 2015 and is headquartered in Canton, Ohio.

NASDAQ ended the session with Hall of Fame Resort & Entertainment Company falling 10.52% to $5.10 on Thursday, after two sequential sessions in a row of losses. NASDAQ dropped 0.12% to $13,219.83, following the last session’s upward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, Hall of Fame Resort & Entertainment Company has a trailing twelve months EPS of $-11.22.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -33.15%.

Volatility

Hall of Fame Resort & Entertainment Company’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.69%, a negative 1.81%, and a positive 3.30%.

Hall of Fame Resort & Entertainment Company’s highest amplitude of average volatility was 4.12% (last week), 3.43% (last month), and 3.30% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 25.3% and positive 36.4% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 128.2%, now sitting on 20.44M for the twelve trailing months.

Volume

Today’s last reported volume for Hall of Fame Resort & Entertainment Company is 36984 which is 134.31% above its average volume of 15784.

More news about Hall of Fame Resort & Entertainment Company.

4. Kezar Life Sciences (KZR) – -9.91%

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of KZR-261; and KZR-TBD for the treatment of oncology and autoimmunity. The company was founded in 2015 and is based in South San Francisco, California.

NASDAQ ended the session with Kezar Life Sciences sliding 9.91% to $0.91 on Thursday while NASDAQ fell 0.12% to $13,219.83.

Earnings Per Share

As for profitability, Kezar Life Sciences has a trailing twelve months EPS of $-1.02.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -31.17%.

Yearly Top and Bottom Value

Kezar Life Sciences’s stock is valued at $0.91 at 17:32 EST, way below its 52-week high of $8.50 and above its 52-week low of $0.91.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Kezar Life Sciences’s EBITDA is 2.5.

More news about Kezar Life Sciences.

5. Kaixin Auto Holdings (KXIN) – -9.6%

Kaixin Auto Holdings operates as a used car dealership in the People's Republic of China. As of December 31, 2020, the company had 14 dealerships. It also provides financing channels to its customers through its partnership with financial institutions; and value-added services to its customers, including insurance, extended warranties, and after-sales services. The company was founded in 2015 and is headquartered in Beijing, the People's Republic of China. Kaixin Auto Holdings is a subsidiary of Renren Inc.

NASDAQ ended the session with Kaixin Auto Holdings dropping 9.6% to $1.13 on Thursday while NASDAQ dropped 0.12% to $13,219.83.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -230%.

Moving Average

Kaixin Auto Holdings’s value is way under its 50-day moving average of $3.04 and way under its 200-day moving average of $4.91.

More news about Kaixin Auto Holdings.

6. BlackBerry (BB) – -9.13%

BlackBerry Limited provides intelligent security software and services to enterprises and governments worldwide. The company operates through three segments: Cybersecurity, IoT, and Licensing and Other. The company offers CylancePROTECT, an endpoint protection platform and mobile threat defense solution; CylanceOPTICS, an endpoint detection and response solution; CylanceGUARD, a managed detection and response solution; CylanceGATEWAY, an AI-empowered zero-trust network access solution; CylancePERSONA, a user and entity behavior analytics solution; BlackBerry unified endpoint management, a central software component for secure communications platform; BlackBerry Dynamics, a development platform and secure container for mobile applications; and BlackBerry Workspaces solutions. It also provides BlackBerry SecuSUITE, a multi-OS voice and text messaging solution; BlackBerry AtHoc and BlackBerry Alert, which are secure and networked critical event management solutions; BlackBerry QNX that offers real-time operating systems, hypervisors, middleware, development tools, and professional services; BlackBerry Certicom, a cryptography and key management product; BlackBerry Radar, an asset monitoring solution; and BlackBerry IVY, an intelligent vehicle data platform. In addition, the company is involved in the patent licensing and legacy service access fees business. The company was formerly known as Research In Motion Limited and changed its name to BlackBerry Limited in July 2013. BlackBerry Limited was incorporated in 1984 and is headquartered in Waterloo, Canada.

NYSE ended the session with BlackBerry dropping 9.13% to $3.88 on Thursday while NYSE rose 0.01% to $15,072.99.

Earnings Per Share

As for profitability, BlackBerry has a trailing twelve months EPS of $-0.96.

Sales Growth

BlackBerry’s sales growth for the next quarter is 30.5%.

Volume

Today’s last reported volume for BlackBerry is 7903530 which is 29.45% above its average volume of 6105390.

More news about BlackBerry.

7. Immatics N.V. (IMTXW) – -9.09%

NASDAQ ended the session with Immatics N.V. sliding 9.09% to $2.60 on Thursday while NASDAQ slid 0.12% to $13,219.83.

Yearly Top and Bottom Value

Immatics N.V.’s stock is valued at $2.60 at 17:32 EST, under its 52-week low of $2.60.

More news about Immatics N.V..

8. Kintara Therapeutics (KTRA) – -8.58%

Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a photodynamic therapy for the treatment of cutaneous metastatic breast cancer. The company has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. Kintara Therapeutics, Inc. was founded in 2009 and is headquartered in San Diego, California.

NASDAQ ended the session with Kintara Therapeutics dropping 8.58% to $3.74 on Thursday, following the last session’s upward trend. NASDAQ dropped 0.12% to $13,219.83, following the last session’s upward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Kintara Therapeutics has a trailing twelve months EPS of $-8.97.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -233.9%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Kintara Therapeutics’s EBITDA is -4.32.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 83.4% and 71.4%, respectively.

Volume

Today’s last reported volume for Kintara Therapeutics is 5841 which is 71.64% below its average volume of 20596.

More news about Kintara Therapeutics.

9. NeuroMetrix (NURO) – -7.95%

NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

NASDAQ ended the session with NeuroMetrix dropping 7.95% to $0.64 on Thursday while NASDAQ fell 0.12% to $13,219.83.

Earnings Per Share

As for profitability, NeuroMetrix has a trailing twelve months EPS of $-0.7.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.14%.

More news about NeuroMetrix.

10. Akerna Corp. (KERN) – -7.74%

Akerna Corp. operates as a technology company. The company offers MJ Platform, an enterprise resource planning system to the cannabis industry; and Leaf Data Systems, a tracking system designed for government agencies. It also provides consulting services to cannabis industry; business intelligence, an infrastructure as a service tool, which delivers supply chain analytics for the cannabis, hemp, and CBD industries; and Last Call Analytics, a subscription analytics tool for alcohol brands to analyze their retail sales analytics. In addition, the company operates seed-to-sale platform that allows cultivators to track and report various stage of their cannabis growing operations, production, and sales processes. Further, it offers cannabis cultivation management and software to manage and optimize operational workflow in business analytics; and cannabis tracking technology that provides seed-to-sale-to-self data. Akerna Corp. was founded in 2010 and is headquartered in Denver, Colorado.

NASDAQ ended the session with Akerna Corp. sliding 7.74% to $0.20 on Thursday, after two consecutive sessions in a row of losses. NASDAQ fell 0.12% to $13,219.83, following the last session’s upward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, Akerna Corp. has a trailing twelve months EPS of $3.18.

PE Ratio

Akerna Corp. has a trailing twelve months price to earnings ratio of 0.06. Meaning, the purchaser of the share is investing $0.06 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -943.66%.

Moving Average

Akerna Corp.’s worth is way below its 50-day moving average of $0.35 and way under its 200-day moving average of $0.72.

Sales Growth

Akerna Corp.’s sales growth is negative 55.7% for the present quarter and negative 39.2% for the next.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 97.4% and 78.7%, respectively.

Volume

Today’s last reported volume for Akerna Corp. is 189745 which is 65.53% below its average volume of 550545.

More news about Akerna Corp..

Stay up to date with our winners and losers daily report